AR and diabetes mellitus: Consistent with this, reported inhibition of diabetes-induced defects in electroretinogram using pharmacologic inhibitors [47]–[49] was not confirmed using AR−/− mice studied by us [50], raising a possibility that some of the observed effects of AR inhibitors were due to off-target effects.